Laboratory Corp of America Holdings (LH)

$276.94 -2.50 (-0.89%)
Market Cap 23.01B
Revenue (ttm) 13.01B
Net Income (ttm) 746.00M
EPS (ttm) N/A
PE Ratio 18.46
Forward PE 17.14
Profit Margin 5.73%
Debt to Equity Ratio 0.60
Volume 716,000
Avg Vol 523,088
Day's Range N/A - N/A
Shares Out 83.10M
Stochastic %K 19%
Beta 0.89
Analysts Strong Sell
Price Target $296.70

Company Profile

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 336-584-5171
Fax: 336-436-1569
Address:
531 South Spring Street, Burlington, United States
MoneyGroupLLC
MoneyGroupLLC Oct. 3 at 11:11 AM
Enter: $LH NOV 21 2025 $280 CALLS Buy in Price: $10.50 - $10.57 Take Profit: $22.73 Stop Bleeding: $9.30 ROI Potential: 115% Exit Within: 299 Minutes https://moneygroup.us/alerts
0 · Reply
SweepCastApp
SweepCastApp Oct. 3 at 4:55 AM
$LH: Unusual Options Activity Alerted PUT flow observed 125x contracts at Strike price of $280 Exp on 10/17/2025 with Premium of $60K and showing BEARISH Sentiment
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 2 at 12:12 PM
$LH Share Price: $279.01 Contract Selected: May 15, 2026 $280 Calls Buy Zone: $17.66 – $21.82 Target Zone: $31.20 – $38.13 Potential Upside: 67% ROI Time to Expiration: 224 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
SweepCastApp
SweepCastApp Oct. 1 at 6:17 PM
$LH: Unusual Options Activity Alerted PUT flow observed 108x contracts at Strike price of $250 Exp on 05/15/2026 with Premium of $68K and showing BULLISH Sentiment
0 · Reply
SilverEagle
SilverEagle Sep. 30 at 4:11 PM
$LH send it.
0 · Reply
highnihilism
highnihilism Sep. 30 at 10:22 AM
$VTRS Viatris: 82 trades, $37K vs $112K avg (0.33x !!). $34K calls / $3K puts. $FSS Federal Signal: 10 trades, $35K vs $23K avg (1.49x). $34K calls / $1K puts. $OLN Olin: 126 trades, $49K vs $219K avg (0.22x !!). $34K calls / $15K puts. $LH Labcorp: 22 trades, $178K vs $167K avg (1.06x). $34K calls / $144K puts.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 30 at 9:15 AM
Enter: $LH NOV 21 2025 $290 CALLS Buy in Price: $7.70 - $8.09 Take Profit: $12.94 Stop Bleeding: $6.78 ROI Potential: 68% Exit Within: 162 Minutes https://moneygroup.us/alerts
0 · Reply
highnihilism
highnihilism Sep. 29 at 6:28 PM
S&P MidCap 400 (Health Care) → $INCY Incyte $JAZZ Jazz Pharmaceuticals $LH Laboratory Corp. of America $MD Mednax $MOH Molina Healthcare
0 · Reply
Doozio
Doozio Sep. 29 at 1:21 AM
$LH it was always 🐒🍌🧠⏰♾️ wen newton got da huckleberries thru da $$$. Let’s ride.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 28 at 11:31 PM
Enter: $LH NOV 21 2025 $290 CALLS Buy in Price: $7.70 - $9.00 Take Profit: $10.01 Stop Bleeding: $6.78 ROI Potential: 30% Exit Within: 77 Minutes https://moneygroup.us/alerts
0 · Reply
Latest News on LH
Labcorp Announces Collaboration with Roche to Advance Digital Pathology Capabilities

Sep 30, 2025, 7:00 AM EDT - 4 days ago

Labcorp Announces Collaboration with Roche to Advance Digital Pathology Capabilities

Labcorp to Announce Third Quarter Financial Results on October 28, 2025

Sep 25, 2025, 4:15 PM EDT - 9 days ago

Labcorp to Announce Third Quarter Financial Results on October 28, 2025

Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

Sep 15, 2025, 8:30 AM EDT - 19 days ago

Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

OPK

Labcorp Holdings Inc. (LH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 9, 2025, 10:26 AM EDT - 25 days ago

Labcorp Holdings Inc. (LH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Labcorp to Speak at the Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 27, 2025, 4:15 PM EDT - 5 weeks ago

Labcorp to Speak at the Morgan Stanley 23rd Annual Global Healthcare Conference

Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease

Aug 18, 2025, 7:00 AM EDT - 6 weeks ago

Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease

Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search

Jul 30, 2025, 7:12 AM EDT - 2 months ago

Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search

Labcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EU

Jul 29, 2025, 7:00 AM EDT - 2 months ago

Labcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EU

These Analysts Boost Their Forecasts On Labcorp Following Better-Than-Expected Q2 Earnings

Jul 25, 2025, 9:45 AM EDT - 2 months ago

These Analysts Boost Their Forecasts On Labcorp Following Better-Than-Expected Q2 Earnings

Labcorp Holdings Inc. (LH) Q2 2025 Earnings Call Transcript

Jul 24, 2025, 2:38 PM EDT - 2 months ago

Labcorp Holdings Inc. (LH) Q2 2025 Earnings Call Transcript

Why Is Testing Giant Labcorp Stock Surging On Thursday?

Jul 24, 2025, 12:27 PM EDT - 2 months ago

Why Is Testing Giant Labcorp Stock Surging On Thursday?

Labcorp raises annual profit forecast on strong diagnostic testing demand

Jul 24, 2025, 7:00 AM EDT - 2 months ago

Labcorp raises annual profit forecast on strong diagnostic testing demand

Labcorp Announces 2025 Second Quarter Results

Jul 24, 2025, 6:50 AM EDT - 2 months ago

Labcorp Announces 2025 Second Quarter Results

Community Health Systems Announces Definitive Agreement to Sell Select Outreach Laboratory Assets to Labcorp

Jul 22, 2025, 4:15 PM EDT - 2 months ago

Community Health Systems Announces Definitive Agreement to Sell Select Outreach Laboratory Assets to Labcorp

CYH

Labcorp Declares Quarterly Dividend

Jul 10, 2025, 6:50 AM EDT - 3 months ago

Labcorp Declares Quarterly Dividend

Labcorp Upgraded To A Buy As Portfolio Grows And Leverage Stays Low

Jun 30, 2025, 6:58 AM EDT - 3 months ago

Labcorp Upgraded To A Buy As Portfolio Grows And Leverage Stays Low

Labcorp to Announce Second Quarter Financial Results on July 24, 2025

Jun 26, 2025, 4:10 PM EDT - 3 months ago

Labcorp to Announce Second Quarter Financial Results on July 24, 2025

ASU, Labcorp, and InStride announce first-of-its-kind diagnostics industry partnership that tackles critical healthcare workforce shortage

Jun 2, 2025, 7:00 AM EDT - 4 months ago

ASU, Labcorp, and InStride announce first-of-its-kind diagnostics industry partnership that tackles critical healthcare workforce shortage

Labcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research

May 30, 2025, 7:00 AM EDT - 4 months ago

Labcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research

Labcorp to Webcast Its Annual Meeting of Shareholders May 15

May 8, 2025, 4:15 PM EDT - 5 months ago

Labcorp to Webcast Its Annual Meeting of Shareholders May 15

Labcorp Holdings Inc. (LH) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 4:21 PM EDT - 5 months ago

Labcorp Holdings Inc. (LH) Q1 2025 Earnings Call Transcript

Labcorp beats quarterly profit estimate on diagnostic test demand

Apr 29, 2025, 6:56 AM EDT - 5 months ago

Labcorp beats quarterly profit estimate on diagnostic test demand

Labcorp Announces 2025 First Quarter Results

Apr 29, 2025, 6:50 AM EDT - 5 months ago

Labcorp Announces 2025 First Quarter Results

Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions

Apr 23, 2025, 7:00 AM EDT - 5 months ago

Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions

Genetic Screening Testing for the Preventive Health Market, 2025-2035 Analysis - Dominated by Exact Science, Labcorp Genetics, Blueprint Genetics, Ambry Genetics, and Genex Diagnostics

Apr 11, 2025, 5:32 AM EDT - 6 months ago

Genetic Screening Testing for the Preventive Health Market, 2025-2035 Analysis - Dominated by Exact Science, Labcorp Genetics, Blueprint Genetics, Ambry Genetics, and Genex Diagnostics

Labcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer's Disease

Apr 2, 2025, 7:00 AM EDT - 6 months ago

Labcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer's Disease

Labcorp to Offer HPV and STI Self-Collection Options in Labcorp Patient Service Centers and Participating Physician Offices Nationwide

Apr 1, 2025, 8:32 AM EDT - 6 months ago

Labcorp to Offer HPV and STI Self-Collection Options in Labcorp Patient Service Centers and Participating Physician Offices Nationwide

Labcorp to Announce First Quarter Financial Results on April 29, 2025

Mar 31, 2025, 4:15 PM EDT - 6 months ago

Labcorp to Announce First Quarter Financial Results on April 29, 2025

Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

Mar 11, 2025, 7:00 AM EDT - 7 months ago

Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

OPK

Labcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans for Patients with Advanced Solid Tumors

Feb 24, 2025, 7:32 AM EST - 7 months ago

Labcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans for Patients with Advanced Solid Tumors

Labcorp Holdings: Focus On Core Strengths For Future Growth, Initiate At 'Hold'

Feb 13, 2025, 2:12 PM EST - 8 months ago

Labcorp Holdings: Focus On Core Strengths For Future Growth, Initiate At 'Hold'

Labcorp Holdings Inc. (LH) Q4 2024 Earnings Call Transcript

Feb 6, 2025, 3:42 PM EST - 8 months ago

Labcorp Holdings Inc. (LH) Q4 2024 Earnings Call Transcript

Labcorp Q4 Earnings: Revenue And EPS Beat, Expects Strong 2025 Growth, Analyst Reiterates Outperform On Stable 2025 Outlook

Feb 6, 2025, 1:22 PM EST - 8 months ago

Labcorp Q4 Earnings: Revenue And EPS Beat, Expects Strong 2025 Growth, Analyst Reiterates Outperform On Stable 2025 Outlook

Labcorp forecasts 2025 revenue above estimates on diagnostic test demand

Feb 6, 2025, 6:55 AM EST - 8 months ago

Labcorp forecasts 2025 revenue above estimates on diagnostic test demand

Labcorp Announces 2024 Fourth Quarter and Full Year Results

Feb 6, 2025, 6:50 AM EST - 8 months ago

Labcorp Announces 2024 Fourth Quarter and Full Year Results

Labcorp to Speak at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 10, 2025, 4:15 PM EST - 9 months ago

Labcorp to Speak at the 43rd Annual J.P. Morgan Healthcare Conference

LABCORP DECLARES QUARTERLY DIVIDEND

Jan 8, 2025, 6:02 PM EST - 9 months ago

LABCORP DECLARES QUARTERLY DIVIDEND

Labcorp to Announce Fourth Quarter Financial Results on February 6, 2025

Jan 8, 2025, 4:15 PM EST - 9 months ago

Labcorp to Announce Fourth Quarter Financial Results on February 6, 2025

Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests

Jan 8, 2025, 8:15 AM EST - 9 months ago

Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests

BIO

Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through Physicians

Dec 17, 2024, 7:00 AM EST - 10 months ago

Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through Physicians

Be Patient, Earn Dividends From Labcorp, The Leading Patient Clinical Lab Brand

Nov 29, 2024, 12:16 PM EST - 11 months ago

Be Patient, Earn Dividends From Labcorp, The Leading Patient Clinical Lab Brand

Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients

Nov 26, 2024, 7:52 AM EST - 11 months ago

Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients

Cinven secures Italian nod to sell minority stake in Synlab to Labcorp

Nov 20, 2024, 4:23 AM EST - 11 months ago

Cinven secures Italian nod to sell minority stake in Synlab to Labcorp

Labcorp CFO Glenn Eisenberg Announces Plans to Retire

Nov 19, 2024, 7:00 AM EST - 11 months ago

Labcorp CFO Glenn Eisenberg Announces Plans to Retire

ONC

Praia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering Experience

Nov 4, 2024, 9:00 AM EST - 11 months ago

Praia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering Experience

Labcorp Holdings Inc. (LH) Q3 2024 Earnings Call Transcript

Oct 24, 2024, 2:00 PM EDT - 1 year ago

Labcorp Holdings Inc. (LH) Q3 2024 Earnings Call Transcript

Laboratory Corp Q3 Earnings Beat Street View, Investors Overlook Hurricane Helene Impact

Oct 24, 2024, 11:25 AM EDT - 1 year ago

Laboratory Corp Q3 Earnings Beat Street View, Investors Overlook Hurricane Helene Impact

Labcorp beats quarterly estimates on diagnostic test demand

Oct 24, 2024, 7:10 AM EDT - 1 year ago

Labcorp beats quarterly estimates on diagnostic test demand

Labcorp Announces 2024 Third Quarter Results

Oct 24, 2024, 6:50 AM EDT - 1 year ago

Labcorp Announces 2024 Third Quarter Results

NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.

Oct 16, 2024, 8:00 AM EDT - 1 year ago

NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.

MoneyGroupLLC
MoneyGroupLLC Oct. 3 at 11:11 AM
Enter: $LH NOV 21 2025 $280 CALLS Buy in Price: $10.50 - $10.57 Take Profit: $22.73 Stop Bleeding: $9.30 ROI Potential: 115% Exit Within: 299 Minutes https://moneygroup.us/alerts
0 · Reply
SweepCastApp
SweepCastApp Oct. 3 at 4:55 AM
$LH: Unusual Options Activity Alerted PUT flow observed 125x contracts at Strike price of $280 Exp on 10/17/2025 with Premium of $60K and showing BEARISH Sentiment
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 2 at 12:12 PM
$LH Share Price: $279.01 Contract Selected: May 15, 2026 $280 Calls Buy Zone: $17.66 – $21.82 Target Zone: $31.20 – $38.13 Potential Upside: 67% ROI Time to Expiration: 224 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
SweepCastApp
SweepCastApp Oct. 1 at 6:17 PM
$LH: Unusual Options Activity Alerted PUT flow observed 108x contracts at Strike price of $250 Exp on 05/15/2026 with Premium of $68K and showing BULLISH Sentiment
0 · Reply
SilverEagle
SilverEagle Sep. 30 at 4:11 PM
$LH send it.
0 · Reply
highnihilism
highnihilism Sep. 30 at 10:22 AM
$VTRS Viatris: 82 trades, $37K vs $112K avg (0.33x !!). $34K calls / $3K puts. $FSS Federal Signal: 10 trades, $35K vs $23K avg (1.49x). $34K calls / $1K puts. $OLN Olin: 126 trades, $49K vs $219K avg (0.22x !!). $34K calls / $15K puts. $LH Labcorp: 22 trades, $178K vs $167K avg (1.06x). $34K calls / $144K puts.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 30 at 9:15 AM
Enter: $LH NOV 21 2025 $290 CALLS Buy in Price: $7.70 - $8.09 Take Profit: $12.94 Stop Bleeding: $6.78 ROI Potential: 68% Exit Within: 162 Minutes https://moneygroup.us/alerts
0 · Reply
highnihilism
highnihilism Sep. 29 at 6:28 PM
S&P MidCap 400 (Health Care) → $INCY Incyte $JAZZ Jazz Pharmaceuticals $LH Laboratory Corp. of America $MD Mednax $MOH Molina Healthcare
0 · Reply
Doozio
Doozio Sep. 29 at 1:21 AM
$LH it was always 🐒🍌🧠⏰♾️ wen newton got da huckleberries thru da $$$. Let’s ride.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 28 at 11:31 PM
Enter: $LH NOV 21 2025 $290 CALLS Buy in Price: $7.70 - $9.00 Take Profit: $10.01 Stop Bleeding: $6.78 ROI Potential: 30% Exit Within: 77 Minutes https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 26 at 10:58 PM
Enter: $LH OCT 17 2025 $280 CALLS Buy in Price: $5.10 - $5.35 Take Profit: $6.53 Stop Bleeding: $4.49 ROI Potential: 28% Exit Within: 196 Minutes https://moneygroup.us/alerts
0 · Reply
SilverEagle
SilverEagle Sep. 25 at 12:50 PM
$LH consolidating above its prior pivot high. Looking for a convincing break out of this ascending triangle.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 25 at 12:17 PM
Enter: $LH OCT 17 2025 $290 CALLS Buy in Price: $2.51 - $4.20 Take Profit: $3.56 Stop Bleeding: $2.21 ROI Potential: 42% Exit Within: 376 Minutes https://moneygroup.us/alerts
0 · Reply
highnihilism
highnihilism Sep. 24 at 7:12 PM
Russell 2000 (Healthcare) → $JAZZ Jazz Pharmaceuticals $LH Labcorp $LMAT LeMaitre Vascular $MD Mednax $MDGL Madrigal Pharmaceuticals
0 · Reply
highnihilism
highnihilism Sep. 24 at 12:33 PM
Russell 2000 (Healthcare) → $JAZZ Jazz Pharmaceuticals $LH Labcorp $LMAT LeMaitre Vascular $MD Mednax $MDGL Madrigal Pharmaceuticals
0 · Reply
SPYmyQQQ
SPYmyQQQ Sep. 24 at 6:32 AM
🚀 New Signal ✅ 🏛️ $LH 🗓️ Sep 24, 2025 💵 Entry: $4.26 🎯 Target (Opt.): $4.37 (+2.57%) 👉 Check bio for full access
0 · Reply
lozzamozza
lozzamozza Sep. 23 at 5:04 PM
$LH
0 · Reply
ZacksResearch
ZacksResearch Sep. 23 at 12:54 PM
$LH up 24.1% in a year — what's driving the surge? 🚀 🔬 Past performance includes strong growth in Biopharma Laboratory Services 💼 Operational efficiency initiatives are aimed at boosting margins 💰 Solid financial health with buybacks and dividends Discover why Labcorp remains a strong buy here 👉 https://www.zacks.com/stock/news/2755482/reasons-to-add-labcorp-stock-to-your-portfolio-right-now?cid=sm-stocktwits-2-2755482-body-13634&ADID=SYND_STOCKTWITS_TWEET_2_2755482_BODY_13634
0 · Reply
ZacksResearch
ZacksResearch Sep. 23 at 11:54 AM
$LH — Buy the dip or stay cautious? Biopharma lab growth and efficiency gains are fueling momentum, but currency and macro pressures remain a headwind. Full bull/bear case on LH 👉 https://www.zacks.com/stock/news/2755482/reasons-to-add-labcorp-stock-to-your-portfolio-right-now?cid=sm-stocktwits-2-2755482-teaser-13633&ADID=SYND_STOCKTWITS_TWEET_2_2755482_TEASER_13633
0 · Reply
RomanBroderick845
RomanBroderick845 Sep. 23 at 10:51 AM
$LH Diagnostic services scale. Healthcare utilization stable. Trading at support of rising channel. Volume pattern constructive.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 23 at 1:41 AM
Enter: $LH OCT 17 2025 $280 CALLS Buy in Price: $6.00 - $7.40 Take Profit: $13.62 Stop Bleeding: $5.28 ROI Potential: 127% Exit Within: 325 Minutes https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 22 at 10:30 AM
Enter: $LH OCT 17 2025 $280 CALLS Buy in Price: $6.00 - $6.10 Take Profit: $12.96 Stop Bleeding: $5.28 ROI Potential: 116% Exit Within: 159 Minutes https://moneygroup.us/alerts
0 · Reply